Conformational analysis and molecular properties of N-(substituted phenylcarbonylamino)-4-(1-hydroxymethylphenyl)-1,2,3,6- tetrahydropyridines

Current Medicinal Chemistry

Volumn 10, Issue 4, 2003, Pages 313-320

  Okoro, Cosmas O ^a   Wilson, Tiffany L ^b   Redda, Kinfe K ^b  

^a TENNESSEE STATE UNIVERSITY   (United States)

^b FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

1,2,3,6 tetrahydropyridine; Anti inflammatory; Conformational; Electron donating; Equiactive; Log P; Mechanics; Phenylcarbonylamino; Physicochemical; Quantum; Surface volume

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3 PIPERIDEINE DERIVATIVE; ANTIINFLAMMATORY AGENT; CARBOXYLIC ACID; HYDRAZIDE DERIVATIVE; INDOMETACIN; INTERMEDIN; LIPID; N PHENYLCARBONYLAMINO 1,2,3,6 TETRAHYDROPYRIDINE DERIVATIVE; PYRIDINIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; CENTRAL NERVOUS SYSTEM DISEASE; COMPUTER PROGRAM; DRUG CONFORMATION; DRUG POTENCY; GASTROINTESTINAL SYMPTOM; HUMAN; JAUNDICE; MOLECULAR MECHANICS; NONHUMAN; QUANTUM MECHANICS; REVIEW; RHEUMATIC DISEASE; STOMACH MUCOSA LESION; STRUCTURE ACTIVITY RELATION; THREE DIMENSIONAL IMAGING;

EID: 0037244984     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867033368303     Document Type: Review

References (48)

1. Andrew, A. C.; Issekutz, C.; Issekutz, T. B. Methods in Enzymolgy, 1988, 162, 301.
2. Isson, B. S.; Ramwell, P.; Paolette, R.; Folco, G.; Granstrom, E. Advances in Prostaglandin, Thromboxane, and Leukotriene Research, Vol 21 A and B, Raven Press: New York, 1991.
3. Ford, S. W.; King, E. K.; Pento, J. T. Drugs of Today, 1984, 20(4), 176.
4. Coutts, R. T.; Casay, A. F. In Pyridine and Reduced Pyridines; Abromovitch, Ed.; Interscience Publishers: New York, 1975; Vol. 14, part 4, pp. 445-524.
5. Coutts, R. T.; Scott, J. R. Can. J. Pharm., 1971, 6(4), 78.
6. Langston, J. W. Life Science, 1985, 36(3), 201.
7. Irwin, I.; Langston, J. W. Life Science, 1985, 36(3), 207.
8. Chiueh, C. C.; Burns, R. S.; Markey, S. P.; Jacobowitz, D. M.; Kopin, I. J. Life Science, 1985, 36(3), 213.
9. Gessner, W.; Brossie, A.; Shen, R.; Abell, C. W. J. Med. Chem., 1985, 28(3), 311.
10. Johannessen, J. N.; Chuang, C. C.; Burns, R. S.; Marksy, S. P. Life Science, 1985, 36(3), 219.
11. Heikkila, R. E.; Hess, A.; Duvoisin, R. C. Life Science, 1985, 36(3), 231.
12. Fuller, R. W.; Steranka, L. R. Life Science, 1985, 36(3), 243.
13. Jarvis, M. F.; Wagner, G. C. Life Science, 1985, 36(3), 249.
14. Heikkila, R. E.; Hess, A.; Duvoisin, R. C. Science, 1984, 224, 1451.
15. Boyce, S.; Kelly, E.; Reavill, C.; Jenner, P.; David, C. Biochem. Pharmacol., 1984, 33(11), 1747.
16. Kula, N. S.; Baldessarini, R. J.; Campbell, A.; Finkelstein, S.; Ram, V. J.; Neumeyer, J. L. Life Science, 1984, 34(26), 2567.
17. Redda, K. K.; Corleto, L. A.; Knaus, E. E. Can. J. Chem., 1979, 57, 2981.
18. Redda, K. K.; Corleto, L. A.; Knaus, E. E. J. Med. Chem., 1979, 22, 1079.
19. Bush, J. S.; Marti, A.; Redda, K. Biochemical and Biophysical Res. Commun., 1985, 130(1), 194.
20. Redda K. K.; Melles, H; Rao, K.N. J. Heterocyclic Chem., 1990, 27, 1041.
21. Redda, K. K.; Rao, K. N.; Heiman, A. S.; Onayemi, F. Y.; Clark, J. B. Chem. Pharm. Bull., 1991, 39, 786.
22. Redda, K. K.; Rao, K.N.; Heiman, A. S.; Melles, H. J. Pharm. Sc., 1992, 81, 463.
23. Rao, K. N.; Redda, K.K.; Onayemi, F. Y.; Melles, H.; Choi, J. J. Heterocyclic Chem., 1995, 32, 307.
24. Choi, J.; Wilson, T. L.; Ly, M. A.; Okoro, C. O.; Onubogu, U. C.; Redda, K.K. Med. Chem. Res., 1995, 5, 281.
25. Pelle, C.J.; Okoro, C. O.; Wilson, T. L.; Onubogu, U. C.; Yoon, K. J.; Redda, K.K. Syn. Commun., 1996, 26(14), 2703.
26. Okoro. C. O.; Wilson, T. L.; Choi, J.; Redda, K.K. Med. Chem. Res., 1997, 7(1), 1.
27. Wilson, T.; Onubogu, U.; Kode, R.; Redda, K. Drugs under experimental and clinical research, 1998, 24(4), 165.
28. Okoro, C. O.; Yoon, K. J.; Wilson. T. L.; Onubogu, U. C.; Eckford, T. S; Redda, K.K. Med. Chem. Res., 1999, 9(2), 133.
29. Przedborski, S.; Vila, M. Clinical Neuroscience Research, 2001, 1(6), 407.
30. Yoon, K. J. P.; Kode, B.; Bowen, L.; Redda, K.K. J. Heterocyclic Chemistry, 2001, 38(1), 69.
31. Knaus, E. E.; Redda, K. K. J. Heterocyclic Chem., 1976, 13, 1237.
32. Tamura, Y.; Miki, Y.; Honda, T.; Ikeda, M. J. Heterocyclic Chemistry, 1972, 9, 865.
33. Yeung, J. M.; Corleto, L. A.; Knaus, E. E. J. Med. Chem., 1982, 25, 720.
34. Wallace, R. G. Organic Preparations and Procedures Int., 1982, 1494, 265.
35. Audrieth, L. F.; Diamond, L. D. J. Am. Chem. Soc., 1954, 76, 4869.
36. Tamura, Y.; Minamikawa, J.; Ikeda, M. Synthesis 1977, 1;
37. Tamura, K.; Minamikawa, J.; Miki, Y.; Matsugashita, S.; Ikeda, M. Tetrahedron Lett., 1972, 40, 4133.
38. Harger, M. J. P. J. Chem. Soc., Chem. Commun., 1979, 768.
39. Tamura, Y.; Minamikawa, J.; Sumoko, K.; Fujii, S.; Ikeda, M. J. Org. Chem., 1973, 38, 1239.
40. Andreae, S.; Schmitz, E. Synthesis, 1991, 327.
41. Vidal, J.; Drouin, J.; Collet, A. J. Chem. Soc., Chem. Commun., 435;
42. Vidal, J.; Guy, L.; Sterin, S.; Collet, A. J. Org. Chem., 1993, 58, 4791.
43. Zinner, G.; Ketz, E. U. Synthesis, 1973, 165;
44. Johnson, C. R.; Kirchoff, R. A.; Corkins, H. G. J. Org. Chem., 1974, 39, 2458.
45. Dolores Edmont, Yvon Buisson, Philippe Treillard, Christophe Plisson, and Jacques Chenault. Synthetic Commun., 2000, 30(20), 217.
46. Martin, Y.C. Quantitative Drug Design, Marcel Dekker, New York, 1978, pp. 103-107.
47. Log, P. Calculator version 4.5, Advanced Chemistry Development, Toronto, ON M5H 3V9, Canada.
48. Winter, C. A.; Risley, E. A.; Nuss, G. W. Proc. Soc. Exp. Biol. Med., 1962, 111, 544.